Ijatarn Plus Tablet 150/12.5 mg

Adult dose

This medication is administered once daily without regard to meals. 1. For patients whose blood pressure is not adequately controlled with monotherapy: - Administer 1 tablet of Irbesartan 150 mg/Hydrochlorothiazide 12.5 mg once daily. - Administer 1 tablet of Irbesartan 300 mg/Hydrochlorothiazide 12.5 mg once daily. - Administer 1 tablet of Irbesartan 300 mg/Hydrochlorothiazide 25 mg once daily.

Child dose

The safety and efficacy of this medication have not been established for pediatric patients and adolescents under 18 years of age.

This medication can cause severe harm to the fetus or newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Women who are pregnant, potentially pregnant, or breastfeeding should not take this medication. Patients who have an allergy to this medication or its ingredients or have very poor kidney function should also not take it. Patients with slightly impaired kidney function or liver dysfunction should particularly exercise caution when taking this medication and consult their physician. This medication may cause side effects such as dizziness, fatigue, and nausea, so caution is advised while driving or operating machinery. Furthermore, the risk of skin cancer may be increased, so exposure to sunlight should be avoided and skin conditions should be regularly checked. Electrolyte imbalances in the blood may occur, so regular blood tests are necessary, and caution should be taken regarding the risk of hypokalemia or hyperkalemia. Interactions may occur with other medications, so patients should inform their doctor or pharmacist of any medications they are currently taking. It is also safest not to use this medication while breastfeeding, and it is not recommended for children and adolescents. In case of overdose, symptoms such as nausea, dehydration, and electrolyte abnormalities may occur, so immediate contact with a medical institution is required. This medication should be stored out of reach of children and kept in its original container.

Serious side effects

• Urticaria
• angioedema
• edema
• jaundice
• anaphylactic shock
• severe allergic reactions
• severe skin adverse reactions
• severe edema or urinary abnormalities
• liver dysfunction (jaundice)
• intestinal vascular edema

Mild side effects

• Dizziness
• fatigue
• nausea/vomiting
• abnormal urination
• increased BUN
• increased creatine kinase
• increased creatinine
• headache
• fainting
• low blood pressure

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, when storing the medication, it is advisable to avoid extremely hot or cold places and to keep it in an area with a temperature between 1°C and 30°C.

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle